香港股市 已收市

Trulieve Cannabis Corp (T0A.MU)

Munich - Munich 延遲價格。貨幣為 EUR。
加入追蹤清單
10.19-0.23 (-2.21%)
市場開市。 截至 08:00AM CEST。
全螢幕
前收市價10.42
開市10.19
買盤10.19 x 無
賣出價10.49 x 無
今日波幅10.19 - 10.19
52 週波幅3.16 - 11.98
成交量50
平均成交量168
市值
Beta 值 (5 年,每月)
市盈率 (最近 12 個月)
每股盈利 (最近 12 個月)
業績公佈日2024年5月08日 - 2024年5月13日
遠期股息及收益率無 (無)
除息日
1 年預測目標價
  • InvestorPlace

    Wall Street Favorites: 3 Cannabis Stocks with Strong Buy Ratings for April 2024

    Cannabis stocks could see higher highs. All thanks to recent legalization in Germany, the addition of a cannabis vote in Florida, growing approval ratings in polls, and speculation it could be favorably mentioned in the election. According to the Pew Research Center, about nine in 10 Americans (88%) said that cannabis should be legal for medical or recreational use. About 57% said cannabis should be legal for both medical and recreational use. About 32% said it should just be legal for medical u

  • InvestorPlace

    Wall Street’s Favorite Cannabis Stocks? 3 Names That Could Make You Filthy Rich

    If you’re looking for Wall Street’s favorite cannabis stocks, you’re most likely to find them amongst the holdings of the AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS), the largest U.S.-listed cannabis exchange traded fund (ETF). MSOS is an actively managed ETF with just under $1 billion in net assets. Its net assets are more than four times those of the next largest fund, Amplify Alternative Harvest ETF (NYSEARCA:MJ), with $243 million in net assets. If you’ve held MSOS since its launch in

  • InvestorPlace

    Cannabis Comeback: 3 Stocks to Snag After the Bubble Burst

    The cannabis sector is one that’s certainly seen its boom-bust cycle play out in relatively impressive time in recent years. Now firmly in the “bust” category among many growth investors, will a resurgence in this space take hold? And, further, what catalysts could justify a sector-wide surge? Aside from U.S. federal legalization progress, I’m skeptical of another rally in this sector. Yes, there’s plenty of growth to be had. And, I certainly think many cannabis stocks may warrant another look u